Incyte (INCY) FY2016 results: revenue $1.1 billion, up 46.7% on the year
Incyte Corp. (INCY) reported revenue of $1.1 billion for fiscal 2016, the year ended 31 December 2016, up 46.7% on the year before. Net income was $104 million, up 1495.8%, and diluted earnings per share $0.54. The figures are the company's own, from the 10-K it filed with the SEC on 14 February 2017.
Revenue
$1.1 billion
+46.7% on the year
FY2009FY2016
Operating margin
13.1%
6.7% a year earlier
FY2009FY2016
Net income
$104 million
+1,495.8% on the year
FY2009FY2016
Diluted EPS
$0.54
+1,700.0% on the year
FY2009FY2016
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2016
FY2015
FY2014
On the year
Last 8 years
Revenue
1,106
754
511
+46.7%
Cost of revenue
58.2
27.0
3.0
+115.7%
Gross profit
1,048
727
508
+44.1%
Gross margin
94.7%
96.4%
99.4%
Research and development
582
480
348
+21.3%
Selling, general and administrative
303
197
166
+54.2%
Operating income
145
50.7
-4.8
+186.3%
Operating margin
13.1%
6.7%
-0.9%
Interest expense
38.7
45.6
46.8
-15.0%
Pre-tax income
107
7.6
-48.5
+1,321.4%
Income tax
3.2
1.0
-0.1
+210.4%
Effective tax rate
3.0%
13.6%
n/a
Net income
104
6.5
-48.5
+1,495.8%
Net margin
9.4%
0.9%
-9.5%
Diluted EPS
$0.54
$0.03
-$0.29
+1,700.0%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2016
FY2015
FY2014
On the year
Last 8 years
Operating cash flow
305
89.4
26.3
+240.9%
Capital expenditure
120
26.0
27.9
+362.6%
Free cash flow
184
63.4
-1.6
+191.0%
Free cash flow margin
16.7%
8.4%
-0.3%
Cash from investing
-232
-105
n/a
Cash from financing
44.6
84.7
n/a
-47.3%
Depreciation and amortisation
58.4
44.9
41.4
+30.2%
Share-based compensation
96.2
69.9
62.2
+37.7%
Diluted shares, weighted
194m
187m
168m
+3.6%
Shares outstanding at period end
189m
187m
171m
+1.2%
Balance sheet
$ million
FY2016
FY2015
FY2014
On the year
Last 8 years
Shareholders' equity
419
171
-81.6
+145.1%
Debt
750
750
841
0.0%
Other liabilities
469
86.5
37.2
+442.7%
Total liabilities and equity
1,639
1,007
796
+62.6%
Fixed assets
168
86.0
81.8
+95.0%
Goodwill
156
n/a
n/a
Intangible assets
270
12.3
2.0
+2,102.4%
Investments
188
222
148
-15.1%
Cash and equivalents
652
521
452
+25.1%
Inventory
4.1
1.8
0.4
+130.3%
Other assets
200
164
112
+21.8%
Total assets
1,639
1,007
796
+62.6%
10-K for the year ended 31 December 2016, filed 14 February 2017: the filing.